JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5426
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.72B
| $5K | ﹤0.01% |
+100
| New | +$5.1K |
2019 Q2
0 quarters
|
|
5427
Invesco CEF Income Composite ETF
PCEF
$776M
| $5K | ﹤0.01% |
217
+3
| +1% | +$67 |
2015 Q4
14 quarters
|
|
5428
POSCO
PKX
$17.4B
| $5K | ﹤0.01% |
100
| – | – |
2013 Q2
24 quarters
|
|
|
LNAI
5429
Lunai Bioworks
LNAI
$5.89M
| $5K | ﹤0.01% |
14
-106
| -88% | -$51.7K |
2019 Q1
1 quarter
|
|
5430
ProShares Short Russell2000
RWM
$155M
| $5K | ﹤0.01% |
120
-105
| -47% | -$4.25K |
2019 Q1
1 quarter
|
|
5431
Schwab Short-Term US Treasury ETF
SCHO
$15.2B
| $5K | ﹤0.01% |
184
-2,912
| -94% | -$73.2K |
2018 Q4
2 quarters
|
|
5432
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.79B
| $5K | ﹤0.01% |
+82
| New | +$4.97K |
2019 Q2
0 quarters
|
|
5433
Tenaris
TS
$28.3B
| $5K | ﹤0.01% |
177
-1,141
| -87% | -$30.5K |
2015 Q3
15 quarters
|
|
|
ICOL
5434
DELISTED
iShares MSCI Colombia ETF
ICOL
| $5K | ﹤0.01% |
400
| – | – |
2017 Q3
7 quarters
|
|
|
JTD
5435
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $5K | ﹤0.01% |
+273
| New | +$4.42K |
2019 Q2
0 quarters
|
|
|
MCEP
5436
DELISTED
Mid-Con Energy Partners, LP
MCEP
| $5K | ﹤0.01% |
522
| – | – |
2015 Q3
15 quarters
|
|
|
SAEX
5437
DELISTED
SAExploration Holdings, Inc.
SAEX
| $5K | ﹤0.01% |
1,456
| – | – |
2018 Q3
3 quarters
|
|
|
SOIL
5438
DELISTED
Global X Fertilizers/Potash ETF
SOIL
| $5K | ﹤0.01% |
500
+472
| +1,686% | +$4.38K |
2019 Q1
1 quarter
|
|
5439
iShares MSCI Ireland ETF
EIRL
$76.2M
| $4K | ﹤0.01% |
87
-34
| -28% | -$1.44K |
2013 Q2
24 quarters
|
|
5440
ProShares UltraShort Euro
EUO
$35.2M
| $4K | ﹤0.01% |
150
-1,975
| -93% | -$50.9K |
2018 Q4
2 quarters
|
|
5441
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$694M
| $4K | ﹤0.01% |
100
| – | – |
2017 Q1
9 quarters
|
|
|
HOOK
5442
DELISTED
HOOKIPA Pharma
HOOK
| $4K | ﹤0.01% |
+57
| New | +$6.05K |
2019 Q2
0 quarters
|
|
5443
NatWest
NWG
$69.9B
| $4K | ﹤0.01% |
698
+226
| +48% | +$1.48K |
2014 Q2
20 quarters
|
|
5444
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$11.4M
| $4K | ﹤0.01% |
200
| – | – |
2018 Q4
2 quarters
|
|
5445
Invesco Energy Exploration & Production ETF
PXE
$88.1M
| $4K | ﹤0.01% |
219
| – | – |
2017 Q1
9 quarters
|
|
|
SCHR
5446
Schwab Intermediately-Term US Treasury ETF
SCHR
$13B
| $4K | ﹤0.01% |
156
| – | – |
2019 Q1
1 quarter
|
|
5447
iShares Russell 2500 ETF
SMMD
$4.08B
| $4K | ﹤0.01% |
+100
| New | +$4.46K |
2019 Q2
0 quarters
|
|
|
SOR
5448
Source Capital
SOR
$370M
| $4K | ﹤0.01% |
+116
| New | +$4.21K |
2019 Q2
0 quarters
|
|
5449
ProShares Ultra Materials
UYM
$34.2M
| $4K | ﹤0.01% |
292
| – | – |
2018 Q4
2 quarters
|
|
5450
Vanguard US Momentum Factor ETF
VFMO
$1.95B
| $4K | ﹤0.01% |
+55
| New | +$4.41K |
2019 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.